...
首页> 外文期刊>American Journal of Physiology >Key role of PKC and Ca2+ in EGF protection of microtubules and intestinal barrier against oxidants.
【24h】

Key role of PKC and Ca2+ in EGF protection of microtubules and intestinal barrier against oxidants.

机译:PKC和Ca2 +在微管EGF保护和抗氧化剂肠屏障中的关键作用。

获取原文
获取原文并翻译 | 示例

摘要

Using monolayers of human intestinal (Caco-2) cells, we showed that growth factors (GFs) protect microtubules and barrier integrity against oxidative injury. Studies in nongastrointestinal cell models suggest that protein kinase C (PKC) signaling is key in GF-induced effects and that cytosolic calcium concentration ([Ca2+](i)) is essential in cell integrity. We hypothesized that GF protection involves activating PKC and maintaining normal ([Ca2+](i)) Monolayers were pretreated with epidermal growth factor (EGF) or PKC or Ca2+ modulators before exposure to oxidants (H2O2 or HOCl). Oxidants disrupted microtubules and barrier integrity, and EGF protected from this damage. EGF caused rapid distribution of PKC-alpha, PKC-betaI, and PKC-zeta isoforms to cell membranes, enhancing PKC activity of membrane fractions while reducing PKC activity of cytosolic fractions. EGF enhanced (45)Ca2+ efflux and prevented oxidant-induced (sustained) rises in ([Ca2+](i)). PKC inhibitors abolished and PKC activators mimicked EGF protection. Oxidant damage was mimicked by and potentiated by a Ca2+ ionophore (A-23187), exacerbated by high-Ca2+ media, and prevented by calcium removal or chelation or by Ca2+ channel antagonists. PKC activators mimicked EGF on both (45)Ca2+ efflux and ([Ca2+](i)). Membrane Ca2+-ATPase pump inhibitors prevented protection by EGF or PKC activators. In conclusion, EGF protection of microtubules and the intestinal epithelial barrier requires activation of PKC signal transduction and normalization of ([Ca2+](i)).
机译:使用人类肠道(Caco-2)细胞单层,我们显示出生长因子(GFs)保护微管和屏障完整性免受氧化损伤。在非胃肠道细胞模型中的研究表明,蛋白激酶C(PKC)信号传导是GF诱导的效应的关键,而胞质钙浓度([Ca2 +](i))对于细胞完整性至关重要。我们假设GF保护涉及激活PKC和维持正常([Ca2 +](i))。单层在暴露于氧化剂(H2O2或HOCl)之前,已使用表皮生长因子(EGF)或PKC或Ca2 +调节剂进行了预处理。氧化剂破坏了微管和屏障的完整性,而EGF免受这种破坏。 EGF导致PKC-alpha,PKC-betaI和PKC-zeta同种型快速分布到细胞膜,增强了膜组分的PKC活性,同时降低了胞质组分的PKC活性。 EGF增强了([Ca2 +](i))中(45)Ca2 +的流出并防止了氧化剂引起的(持续的)升高。 PKC抑制剂被取消,而PKC激活剂模仿了EGF的保护作用。氧化损伤由Ca2 +离子载体(A-23187)模仿和增强,高Ca2 +介质加剧,并通过钙去除或螯合或Ca2 +通道拮抗剂防止。 PKC激活剂模仿(45)Ca2 +外排和([Ca2 +](i))上的EGF。膜Ca2 + -ATPase泵抑制剂阻止EGF或PKC激活剂的保护。总之,微管和肠上皮屏障的EGF保护需要激活PKC信号转导和([Ca2 +](i))正常化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号